Opioid dependence during pregnancy. Effects and management

Area of Science:

• Obstetrics and Gynecology
• Addiction Medicine
• Neonatal Health

Background:

• Opioid dependence during pregnancy poses significant risks to both mother and fetus.
• Comprehensive management requires addressing medical, obstetric, and psychosocial factors.
• Neonatal Abstinence Syndrome (NAS) is a critical concern for infants exposed to opioids in utero.

Purpose of the Study:

• To outline the multifaceted problems of opioid dependence in pregnant individuals.
• To describe methadone maintenance therapy as a treatment for opioid dependence.
• To discuss critical aspects of methadone treatment during pregnancy, including dosing and neonatal outcomes.

Main Methods:

• Literature review and clinical experience synthesis regarding opioid dependence in pregnancy.
• Examination of medical, obstetric, and psychosocial challenges.
• Analysis of methadone maintenance treatment protocols and their impact on neonatal abstinence.

Main Results:

• Opioid dependence during pregnancy is associated with a spectrum of complex medical, obstetric, and psychosocial issues.
• Methadone maintenance therapy is an established treatment approach for opioid-dependent pregnant individuals.
• The relationship between maternal methadone dosage and the severity of neonatal abstinence syndrome is a key consideration.

Conclusions:

• Effective management of opioid dependence in pregnancy necessitates a multidisciplinary approach.
• Optimizing methadone dosage is vital for mitigating risks to the neonate, particularly NAS.
• Continued research and clinical attention are needed to improve outcomes for pregnant individuals with opioid use disorder and their infants.